OPPI releases Shaping India’s OTC Policy 2018

Pharma/BioPharma |  News | 0 Comment | 12 Oct, 2018

On behalf of the pharmaceutical industry in India, the Organisation of Pharmaceutical Producers of India (OPPI), along with a few members from the domestic pharmaceutical industry and consu...Read more

OPPI advocates for policies that promote scientific temperament

Pharma/BioPharma |  News | 0 Comment | 11 Oct, 2018

The Organisation of Pharmaceutical Producers of India (OPPI) celebrated their 52nd Annual Day recently. Themed #HealthMeetsHope, the Chief Guest of the Annual Day celebrations, Shri. Sidhar...Read more

Armas, Shilpa ink distribution pact for oncology products

Pharma/BioPharma |  News | 0 Comment | 09 Oct, 2018

Armas Pharmaceuticals Inc., a NJ based pharmaceutical marketing & distribution corporation, and Shilpa Medicare Limited, a Karnataka based pharmaceutical company, have announced a distr...Read more

Zydus receives final approval for Exemestane Tablets

Pharma/BioPharma |  News | 0 Comment | 05 Oct, 2018

Zydus Cadila has received the final approval from the USFDA to market Exemestane Tablets, (US RLD – AROMASIN Tablets), 25 mg. It will be manufactured at the group’s formulations...Read more

Lupin, Lilly partner for innovative diabetes treatment in India

Pharma/BioPharma |  News | 0 Comment | 03 Oct, 2018

Pharma Major Lupin Limited and Eli Lilly and Company (India) Pvt. Ltd., have announced the expansion of their business partnership aimed at widening access to innovative diabetes medicines ...Read more

Rotavirus vaccine options expand with WHO prequalification

Pharma/BioPharma |  News | 0 Comment | 28 Sep, 2018

PATH welcomes the World Health Organization's (WHO's) prequalification of the thermostable rotavirus vaccine, ROTASIIL, manufactured by Serum Institute of India. The vaccine, which prevents...Read more

AstraZeneca receives European marketing authorisation for Imfinzi

Pharma/BioPharma |  News | 0 Comment | 25 Sep, 2018

AstraZeneca and MedImmune, its global biologics research and development arm, have announced that the European Commission has granted marketing authorisation for Imfinzi (durvalumab) as mon...Read more

Glenmark gets USFDA approval for menopause symptom relief drug

Pharma/BioPharma |  News | 0 Comment | 17 Sep, 2018

Glenmark Pharmaceuticals has received final approval from the US health regulator for a generic version of Nordisk Inc's VAGIFEM, used for providing relief from menopause symptom. Glenmark...Read more

Alembic Pharma receives approval for diabetes drug

Pharma/BioPharma |  News | 0 Comment | 16 Sep, 2018

Alembic Pharmaceuticals has said that it has received tentative approval from the US health regulator to market Alogliptin and Metformin Hydrochloride tablets, an anti-diabetes medication, ...Read more

Kusum Group launches Rs 90 Cr Manufacturing Plant in Indore

Pharma/BioPharma |  News | 0 Comment | 12 Sep, 2018

Pharmaceutical major Kusum Group of Companies has announced the launch of its latest 90 crore Indore plant at the special economic zone in Pithampur. Built on an area of over 4.88 acres, th...Read more

Pharma outlook stable despite intensifying profitability headwinds

Pharma/BioPharma |  News | 0 Comment | 04 Sep, 2018

India Ratings and Research (Ind-Ra) has maintained a stable outlook for the pharmaceutical sector for the rest of FY19. The domestic pharmaceutical market growth is likely to remain robust...Read more

GNG, DMIMS to develop bio-banks for cancer tissues

Pharma/BioPharma |  News | 0 Comment | 28 Aug, 2018

GeNext Genomics Pvt. Ltd (GNG) and Research Cell, Datta Meghe Institute of Medical Sciences (DMIMS) have signed a Memorandum of Understanding (MoU) for collaboration to develop Bio-Banking ...Read more

Ozempic reduces major cardiovascular risk in Type 2 diabetics

Pharma/BioPharma |  News | 0 Comment | 27 Aug, 2018

Novo Nordisk’s  Ozempic® (semaglutide) consistently reduced the risk of the composite outcome of time to first occurrence of non-fatal heart attack, non-fatal stroke or cardi...Read more

Cadila to acquire majority stake in Windlas Healthcare

Pharma/BioPharma |  News | 0 Comment | 20 Aug, 2018

Cadila Healthcare Ltd, which operates under the Zydus Cadila brand, has agreed to acquire a 51 per cent stake in pharmaceuticals company Windlas Healthcare Pvt. Ltd for Rs 155.5 crore. The ...Read more

Merck snatches Australian CRISPR nickase patent

Pharma/BioPharma |  News | 0 Comment | 16 Aug, 2018

Merck, the vibrant science and Technology Company announced that the Australian Patent Office has allowed the company's patent application for the use of paired CRISPR nickases. Paired nic...Read more

Pharma exports to cross $19 B in FY19: Pharmexcil

Pharma/BioPharma |  News | 0 Comment | 14 Aug, 2018

Pharmaceutical exports from the country are expected to cross $19 billion in worth during the current fiscal despite muted growth in the North American markets, according to Pharmexcil, a b...Read more

PharmaLytica 2018 highlights Quality Culture and Regulatory Compliance trends of the Pharma Sector

Pharma/BioPharma |  News | 0 Comment | 13 Aug, 2018

UBM India, the organisers of CPhI / P-MEC India, the leading global pharma trade show and conference, recently hosted the 5th edition of PharmaLytica 2018 in Hyderabad at the HITEX Exhibiti...Read more

Cipla gets selling rights for cancer drug in US

Pharma/BioPharma |  News | 0 Comment | 11 Aug, 2018

Drug major Cipla said its subsidiary has secured rights from Hyderabad-based MSN Laboratories to market and distribute colon cancer treatment drug Capecitabine in the US market.   Ci...Read more